1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack
RxNorm 2045244

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2045244 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack
AUI:10823854
View
GPCK
{1 (ascorbic acid 7540 mg / polyethylene glycol 3350 40000 mg / potassium chloride 1200 mg / sodium ascorbate 48110 mg / sodium chloride 3200 mg Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 mg / potassium chloride 1000 mg / sodium chloride 2000 mg / sodium sulfate 9000 mg Powder for Oral Solution) } Pack
AUI:12372709
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack
(Atom ID: 10823854)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2045244
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
10823854
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2045244
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCKPrescribable

Generic Pack (GPCK):
{1 (ascorbic acid 7540 mg / polyethylene glycol 3350 40000 mg / potassium chloride 1200 mg / sodium ascorbate 48110 mg / sodium chloride 3200 mg Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 mg / potassium chloride 1000 mg / sodium chloride 2000 mg / sodium sulfate 9000 mg Powder for Oral Solution) } Pack
(Atom ID: 12372709)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2045244
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372709
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
2045244
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Polyethylene glycol-electrolyte solution (PEG-ES)


Polyethylene glycol-electrolyte solution (PEG-ES) is used to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) or barium enema (a test in which the colon is filled with a fluid and then x-rays are taken) so that the doctor will have a clear view of the walls of the colon. PEG-ES is in a class of medications called osmotic laxatives. It works by causing watery diarrhea so that the stool can be emptied from the colon. The medication also contains electrolytes to prevent dehydration and other serious side effects that may be caused by fluid loss as the colon is emptied.
[Learn More]


Vitamin C



[Learn More]


* Please review the disclaimer below.